Medizinische Universität Graz - Research portal
Odar Corinna Beate |
Presentations at scientific and public conferences
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Kühberger, S; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
A Liquid biopsy multi-analyte approach deciphering treatment resistance in prostate cancer supported by machine learning
EACR Liquid Biopsy; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
Longitudinal tracking of drug resistance in metastatic prostate cancer
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
CTC characterization by multiplex mRNA in situ hybridization and machine learning-assisted classification for longitudinal monitoring of drug resistance in metastatic prostate cancer.
6th ACTC Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Characterization of circulating tumor cells by combinatorial dual-color (CoDuCo) in situ padlock probe hybridization and supervised machine-learning.
Applications of In Situ Hybridisation and Spatial Profiling Methods in Research and Disease; MAY 16-17, 2023; Cambridge, UK. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Herbsthofer, L; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Spotting the difference: rare cell characterization by multiplex mRNA in situ hybridization and machine learning in the context of liquid biopsy-based therapy resistance monitoring.
13th International Symposium on Minimal Residual Cancer ISMRC; MAY 2-4, 2023; Hamburg, GERMANY. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Zinnegger, M; Skofler, C; Ulz, C; Pankratz, K; Pritz, E; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Tracking drug resistance in metastatic prostate cancer: longitudinal CTC characterization using multiplex mRNA in situ hybridization and machine learning-assisted classification.
General Assembly of the European Liquid Biopsy Society ELBS; NOV 9-10, 2023; Rome, ITALY. 2023.
[Oral Communication]